文献速递颈动脉与弓上血管

女性和男性患者在前瞻性试验中经颈动脉血运重建术后结局相似

Female and male patients have similar outcomes after transcarotid artery revascularization in prospective trials.
PubMed 文献 · J Vasc Surg · 2023-09-15

分析ROADSTER1、ROADSTER2和ROADSTER扩展准入TCAR试验中910例患者(女性306例,男性604例),比较经颈动脉血运重建术(TCAR)后30天卒中/死亡(S/D)和卒中/死亡/心肌梗死(S/D/M)结局。结果显示男女患者S/D和S/D/M发生率相似,未因性别而异。

要点

  • TCAR术后30天S/D率男性2.7% vs 女性1.6%(P=.34),S/D/M率男性3.6% vs 女性2.6%(P=.41)。
  • 按症状状态分层后,男女患者S/D和S/D/M率仍无差异。
  • 女性患者血流逆转时间较长(男性10.9分钟 vs 女性12.4分钟;P=.01),造影剂用量较多(男性43 mL vs 女性48.9 mL;P=.049)。

核心结论

  • 前瞻性TCAR试验数据显示S/D/MI发生率极低,且不因患者性别而异。

研究设计与样本

  • 分析ROADSTER1(关键性)、ROADSTER2(美国食品药品监督管理局指示的上市后)和ROADSTER扩展准入TCAR试验的前瞻性收集数据。
  • 共纳入910例患者(女性306例[33.6%],男性604例[66.4%]),均经证实颈动脉狭窄符合干预标准(无症状患者≥80%,有症状患者≥50%),并基于解剖或临床高危标准入选。
  • 由独立神经科医生或美国国立卫生研究院卒中量表认证护士在术前和术后24小时内进行神经系统评估。
  • 按性别分层(男性 vs 女性),使用χ2检验和Fisher精确检验比较基线人口学特征,采用单因素逻辑回归分析。

主要发现

  • 女性患者较男性更常<65岁(20.6% vs 15%)或≥80岁(22.6% vs 20.2%),黑种人/非裔美国人比例更高(7.5% vs 4.3%)。
  • 男女患者在合并症、吸烟状态、既往卒中、症状状态或解剖/临床高危标准患病率方面无差异。
  • 女性患者血流逆转时间较长(男性10.9分钟 vs 女性12.4分钟;P=.01),造影剂用量较多(男性43 mL vs 女性48.9 mL;P=.049)。
  • 30天S/D率男性2.7% vs 女性1.6%(P=.34),S/D/M率男性3.6% vs 女性2.6%(P=.41),按症状状态分层后仍无差异。
  • 30天卒中率男性2.2% vs 女性1.6%(P=.80),按症状状态分层后无差异。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Sex disparities in outcomes after carotid revascularization have long been a concern, with several studies demonstrating increased postoperative death and stroke for female patients after either carotid endarterectomy or transfemoral stenting. Adverse events after transfemoral stenting are higher in female patients, particularly in symptomatic cases. Our objective was to investigate outcomes after transcarotid artery revascularization (TCAR) stratified by patient sex hypothesizing that the results would be similar between males and females. METHODS: We analyzed prospectively collected data from the Safety and Efficacy Study for Reverse Flow Used During Carotid Artery Stenting Procedure (ROADSTER)1 (pivotal), ROADSTER2 (US Food and Drug Administration indicated postmarket), and ROADSTER Extended Access TCAR trials. All patients had verified carotid stenosis meeting criteria for intervention (≥80% for asymptomatic patients and ≥50% in patient with symptomatic disease), and were included based on anatomical or clinical high-risk criteria for carotid stenting. Neurological assessments (National Institutes of Health Stroke Scale, Modified Rankin Scale) were obtained before and within 24 hours from procedure end by an independent neurologist or National Institutes of Health Stroke Scale-certified nurse. Patients were stratified by sex (male vs female). Baseline demographics were compared using χ2 and Fisher's exact tests where appropriate; primary outcomes were combination stroke/death (S/D) and S/D/myocardial infarction (S/D/M) at 30 days, and secondary outcomes were the individual components of S/D/M. Univariate logistic regression was conducted. RESULTS: We included 910 patients for analysis (306 female [33.6%], 604 male [66.4%]). Female patients were more often <65 years old (20.6% vs 15%) or ≥80 years old (22.6% vs 20.2%) compared with males, and were more often of Black/African American ethnicity (7.5% vs 4.3%). There were no differences by sex in term of comorbidities, current or prior smoking status, prior stroke, symptomatic status, or prevalence of anatomical and/or clinical high-risk criteria. General anesthetic use, stent brands used, and procedure times did not differ by sex, although flow reversal times were longer in female patients (10.9 minutes male vs 12.4 minutes female; P = .01), as was more contrast used in procedures for female patients (43 mL male vs 48.9 mL female; P = .049). The 30-day S/D and S/D/M rates were similar between male and female patients (S/D, 2.7% male vs 1.6% female [P = .34]; S/D/M, 3.6% male vs 2.6% female [P = .41]), which did not differ when stratified by symptom status. Secondary outcomes did not differ by sex, including stroke rates at 30 days (2.2% male vs 1.6% female; P = .80), nor were differences seen with stratification by symptom status. Univariate analysis demonstrated that history of a prior ipsilateral stroke was associated with increased odds of S/D (odds ratio [OR], 4.19; P = .001) and S/D/M (OR, 2.78; P = .01), as was symptomatic presentation with increased odds for S/D (OR, 2.78; P = .02). CONCLUSIONS: Prospective TCAR trial data demonstrate exceptionally low rates of S/D/MI, which do not differ by patient sex.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Smith JA, Chung JM, Schneider PA, et al. Female and male patients have similar outcomes after transcarotid artery revascularization in prospective trials. J Vasc Surg. 2023. PMID: 37716579. doi:10.1016/j.jvs.2023.09.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。